Hazard
420 recalls in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.
Of the 420 particulate matter recalls we have scored against our rubric, 60 (14%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 189 (45%) are Severe.
Which agencies issued them
Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all particulate matter recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.
A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.
Apollo Care, LLC is recalling specific lots of Semaglutide 6.75mg vials because they contain nylon and silk-type particulate matter.
Baxter Healthcare is recalling 19,032 bags of Cefazolin Injection due to the presence of particulate matter. The affected product is distributed nationwide in the US.
Apollo Care, LLC is recalling 4,748 vials of Semaglutide 0.9mg due to the presence of nylon and silk particulate matter.
Apollo Care, LLC is recalling 56,918 vials of Semaglutide 12.5mg due to the presence of nylon and silk particulate matter.
Apollo Care, LLC is recalling 250 vials of Semaglutide 5mg due to the presence of nylon and silk-type particulate matter.
Apollo Care, LLC is recalling specific lots of Semaglutide 20mg vials because they contain nylon and silk-type particulate matter.
Apollo Care is recalling 250 vials of Semaglutide 7.5mg due to the presence of nylon and silk-type particulate matter.
Apollo Care, LLC is recalling 9,762 vials of Semaglutide 4.5mg due to the presence of nylon and silk-type particulate matter.
Apollo Care, LLC is recalling 500 vials of Semaglutide 10mg due to the presence of nylon and silk-type particulate matter.
Apollo Care, LLC is recalling 250 vials of Semaglutide 2.5mg due to the presence of nylon and silk particulate matter.
Apollo Care, LLC is recalling specific lots of Semaglutide 2.25mg vials because they contain nylon and silk-type particulate matter.
Apollo Care, LLC is recalling specific lots of Semaglutide 9mg vials because they contain nylon and silk-type particulate matter.
Sunny Pharmtech Inc. is recalling 4,077 vials of Cyclophosphamide for Injection due to stainless steel particulate matter found in the product. The recall affects vials distributed nationwide in the USA.
Cyclophosphamide for Injection, USP, 2 gram/vial, is being recalled due to the presence of particulate matter identified as stainless steel. The recall affects 1,464 vials distributed nationwide.
Mylan Pharmaceuticals is recalling one lot of Mycophenolate Mofetil for Injection, 500 mg/vial, because precipitate was found in the vials. The recall covers 5,688 vials distributed nationwide.
Fresenius Kabi is recalling 92,600 vials of NAROPIN (ropivacaine hydrochloride) injection, 0.5%, 10/2028, due to the presence of particulate matter, including hair, found in the product.
Fresenius Kabi is recalling 93,250 vials of Xylocaine (lidocaine HCl) injection due to the presence of particulate matter, specifically hair found in the product.
Fresenius Kabi is recalling Glycopyrrolate Injection due to the presence of particulate matter, specifically hair found in the product.
Buprenorphine HCl Injection, 0.3 mg/mL single dose vials, is being recalled because of crystallization identified as buprenorphine free base. 46,334 units are affected.
Doxorubicin Hydrochloride Liposome Injection, 50 mg/25 mL single-dose vials, is being recalled because of particulate matter identified as glass. 675 vials are affected.
Lupin Pharmaceuticals is recalling Liraglutide Injection due to the presence of white thread-like structures (particulate matter) found in cartridges. The recall affects 217,621 pen injectors distributed nationwide.
Endo USA, Inc. is recalling Buprenorphine Hydrochloride injection vials distributed nationwide due to the presence of particulate matter identified as Buprenorphine free base. The FDA classified this as a Class II recall.
B. Braun Medical Inc. is recalling Lactated Ringer's Injection USP (1000 mL containers) due to the presence of particulate matter. The recall affects 95,412 containers distributed nationwide.
GE Healthcare is recalling Omnipaque (iohexol) Injection, 350 mg/mL, over the presence of particulate matter. The action covers 306,810 vials distributed nationwide.
GE Healthcare is recalling Omnipaque (iohexol) Injection, 300 mg/mL, over the presence of particulate matter. The action covers 866,570 vials distributed nationwide.